These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32215658)

  • 1. Something old, something new: a paradigm for considering immune therapies for cardiovascular disease.
    Weber BN; Blankstein R
    Cardiovasc Res; 2020 Apr; 116(5):e51-e53. PubMed ID: 32215658
    [No Abstract]   [Full Text] [Related]  

  • 2. Colchicine for the treatment of cardiovascular diseases: old drug, new targets.
    Andreis A; Imazio M; De Ferrari GM
    J Cardiovasc Med (Hagerstown); 2021 Jan; 22(1):1-8. PubMed ID: 32858634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine in coronary disease: another renaissance of an ancient drug.
    Fiolet ATL; Thompson PL; Mosterd A
    Cardiovasc Res; 2021 Jan; 117(1):e4-e6. PubMed ID: 33426561
    [No Abstract]   [Full Text] [Related]  

  • 4. Colchicine Use in Acute Coronary Syndromes: An Update.
    Tapoi L; Benchea L; Siriopol D; Kanbay M; Covic A
    Angiology; 2021 Jul; 72(6):503-510. PubMed ID: 33412929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Colchicine treatment after myocardial infarction : Colchicine Cardiovascular Outcomes Trial (COLCOT)].
    Klingenberg R; Nitschmann S
    Internist (Berl); 2020 Jul; 61(7):766-769. PubMed ID: 32103281
    [No Abstract]   [Full Text] [Related]  

  • 6. Old Drugs for New Indications in Cardiovascular Medicine.
    Arbel Y; Abuzeid W; Rosenson RS; Weisman A; Farkouh ME
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):223-232. PubMed ID: 29633048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Suppressing Inflammation in the Treatment of Atherosclerotic Cardiovascular Disease.
    Roman YM; Hernandez AV; White CM
    Ann Pharmacother; 2020 Oct; 54(10):1021-1029. PubMed ID: 32425120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
    Kofler T; Kurmann R; Lehnick D; Cioffi GM; Chandran S; Attinger-Toller A; Toggweiler S; Kobza R; Moccetti F; Cuculi F; Jolly SS; Bossard M
    J Am Heart Assoc; 2021 Aug; 10(16):e021198. PubMed ID: 34369166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment.
    Fragoulis GE; Panayotidis I; Nikiphorou E
    Curr Vasc Pharmacol; 2020; 18(5):431-446. PubMed ID: 31258091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of colchicine on patients with acute and chronic coronary artery disease.
    Madanchi M; Young M; Tersalvi G; Maria Cioffi G; Attinger-Toller A; Cuculi F; Kurmann R; Bossard M
    Eur J Intern Med; 2024 Jul; 125():1-9. PubMed ID: 38238134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine's Role in Cardiovascular Disease Management.
    Buckley LF; Libby P
    Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1031-1041. PubMed ID: 38511324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines as therapeutic targets for cardio- and cerebrovascular diseases.
    Liberale L; Ministrini S; Carbone F; Camici GG; Montecucco F
    Basic Res Cardiol; 2021 Mar; 116(1):23. PubMed ID: 33770265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine in Patients with Chronic Coronary Disease.
    Nidorf SM; Fiolet ATL; Mosterd A; Eikelboom JW; Schut A; Opstal TSJ; The SHK; Xu XF; Ireland MA; Lenderink T; Latchem D; Hoogslag P; Jerzewski A; Nierop P; Whelan A; Hendriks R; Swart H; Schaap J; Kuijper AFM; van Hessen MWJ; Saklani P; Tan I; Thompson AG; Morton A; Judkins C; Bax WA; Dirksen M; Alings M; Hankey GJ; Budgeon CA; Tijssen JGP; Cornel JH; Thompson PL;
    N Engl J Med; 2020 Nov; 383(19):1838-1847. PubMed ID: 32865380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and cardiovascular diseases: lessons from seminal clinical trials.
    Liberale L; Montecucco F; Schwarz L; Lüscher TF; Camici GG
    Cardiovasc Res; 2021 Jan; 117(2):411-422. PubMed ID: 32666079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire?
    Giannopoulos G; Angelidis C; Papoutsidakis N; Panagopoulou V; Cleman MW; Lekakis J; Deftereos S
    Curr Med Chem; 2015; 22(36):4177-88. PubMed ID: 26467282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the Role of Colchicine in Cardiovascular Disease.
    Banco D; Mustehsan M; Shah B
    Curr Cardiol Rep; 2024 Apr; 26(4):191-198. PubMed ID: 38340273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation May be the Future of Cardiovascular Risk Reduction: Does Colchicine have a Current Indication?
    Whayne TF
    Am J Cardiovasc Drugs; 2021 Jan; 21(1):1-10. PubMed ID: 32356107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine for the treatment of the spectrum of cardiovascular diseases: current evidence and ongoing perspectives.
    Imazio M; Agrimi C; Cescon L; Panzolli G; Collini V; Sinagra G
    J Cardiovasc Med (Hagerstown); 2024 Sep; 25(9):653-663. PubMed ID: 38916229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-inflammatory therapy in cardiovascular disease; from hypothesis to future guideline?].
    Hoogeveen RM; Stroes ESG; Cornel JH
    Ned Tijdschr Geneeskd; 2020 Oct; 164():. PubMed ID: 33201620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why the CANTOS Is a Game Changer in Cardiovascular Medicine.
    Abbate A
    J Cardiovasc Pharmacol; 2017 Dec; 70(6):353-355. PubMed ID: 29216016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.